Table of Contents

company-logo

CombiGene AB (publ) engages in the development of gene therapy for severe life-altering diseases in Sweden. The company is developing two gene therapy candidates, including CG01, which is in preclinical studies for the treatment of epilepsy and biodistribution and toxicology studies; and CGT2 for the treatment of lipodystrophy. The company has a licensing and collaboration agreement with Lipigon Pharmaceuticals AB to develop a gene therapy treatment for partial lipodystrophy; and with Spark Therapeutics to develop adeno-associated virus (AAV) based gene therapies. CombiGene AB (publ) was founded in 1999 and is headquartered in Lidingö, Sweden.

CombiGene Dividend Announcement

• CombiGene does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on CombiGene dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

CombiGene Dividend History

CombiGene Dividend Yield

CombiGene current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing CombiGene stock? Use our calculator to estimate your expected dividend yield:

CombiGene Financial Ratios

P/E ratio-1.26
PEG ratio0.39
P/B ratio0.55
ROE-37.16%
Payout ratio0.00%
Current ratio14.29
Quick ratio14.29
Cash Ratio14.08

CombiGene Dividend FAQ

Does CombiGene stock pay dividends?
CombiGene does not currently pay dividends to its shareholders.
Has CombiGene ever paid a dividend?
No, CombiGene has no a history of paying dividends to its shareholders. CombiGene is not known for its dividend payments.
Why doesn't CombiGene pay dividends?
There are several potential reasons why CombiGene would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will CombiGene ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While CombiGene has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is CombiGene a dividend aristocrat?
CombiGene is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is CombiGene a dividend king?
CombiGene is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is CombiGene a dividend stock?
No, CombiGene is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy CombiGene stocks?
To buy CombiGene you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy CombiGene stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.